{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T07:12:24Z","timestamp":1648797144153},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T00:00:00Z","timestamp":1526601600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13256-018-1691-2","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T12:48:00Z","timestamp":1525265280000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-term familial Mediterranean fever remission on successful hepatitis C virus treatment in a patient not responding to colchicine: a case report"],"prefix":"10.1186","volume":"12","author":[{"given":"Manik","family":"Gemilyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gagik","family":"Hakobyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Ananyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,18]]},"reference":[{"issue":"6","key":"1691_CR1","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","volume":"140","author":"DL Kastner","year":"2010","unstructured":"Kastner DL, Aksentijevich I, Goldbach-Mansky R. Autoinflammatory Disease Reloaded: A Clinical Perspective. Cell. 2010;140(6):784\u201390.","journal-title":"Cell"},{"key":"1691_CR2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fmicb.2016.00456","volume":"7","author":"G Manukyan","year":"2016","unstructured":"Manukyan G, Aminov R. Update on Pyrin Functions and Mechanisms of Familial Mediterranean Fever. Front Microbiol. 2016;7:456. \n                    https:\/\/doi.org\/10.3389\/fmicb.2016.00456\n                    \n                  .","journal-title":"Front Microbiol"},{"issue":"2","key":"1691_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"E-K Jo","year":"2016","unstructured":"Jo E-K, Kim JK, Shin D-M, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016;13(2):148\u201359.","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"1691_CR4","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/eci.12170","volume":"43","author":"P Portincasa","year":"2013","unstructured":"Portincasa P, Scaccianoce G, Palasciano G. Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder. Eur J Clin Investig. 2013;43(12):1314\u201327.","journal-title":"Eur J Clin Investig"},{"issue":"3","key":"1691_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1574-695X.2008.00385.x","volume":"52","author":"TK Davtyan","year":"2008","unstructured":"Davtyan TK, Harutyunyan VA, Hakobyan GS, Avetisyan SA. Heightened endotoxin susceptibility of monocytes and neutrophils during familial Mediterranean fever. FEMS Immunol Med Microbiol. 2008;52(3):370\u20138.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"4 Suppl 34","key":"1691_CR6","first-page":"S4","volume":"22","author":"H Amital","year":"2004","unstructured":"Amital H, Ben-Chetrit E. Therapeutic approaches to familial Mediterranean fever. What do we know and where are we going to? Clin Exp Rheumatol. 2004;22(4 Suppl 34):S4\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"4 Suppl 30","key":"1691_CR7","first-page":"S49","volume":"21","author":"M Tunca","year":"2003","unstructured":"Tunca M, Ben-Chetrit E. Familial Mediterranean fever in 2003. Pathogenesis and management. Clin Exp Rheumatol. 2003;21(4 Suppl 30):S49\u201352.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"1691_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/clpt.2013.148","volume":"95","author":"I Grattagliano","year":"2014","unstructured":"Grattagliano I, Bonfrate L, Ruggiero V, Scaccianoce G, Palasciano G, Portincasa P. Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics. Clin Pharmacol Ther. 2014;95(1):89\u201397.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"1691_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jhep.2014.05.001","volume":"61","author":"European Association for the Study of the Liver","year":"2014","unstructured":"European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2014. J Hepatol. 2014;61(2):373\u201395.","journal-title":"J Hepatol"},{"key":"1691_CR10","series-title":"Abstr Book Autoinflammation 2010 6th Int Conf FMF Autoinflammatory Dis","first-page":"31","volume-title":"The effect of H. pylori eradication in colchicine-resistant Familial Mediterranean Fever (FMF) patients","author":"G Hakobyan","year":"2010","unstructured":"Hakobyan G, Gemilyan M, Davtyan T. The effect of H. pylori eradication in colchicine-resistant Familial Mediterranean Fever (FMF) patients, Abstr Book Autoinflammation 2010 6th Int Conf FMF Autoinflammatory Dis; 2010. p. 31\u20132."},{"issue":"4","key":"1691_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1089\/jir.1995.15.317","volume":"15","author":"Y Huang","year":"1995","unstructured":"Huang Y, Blatt LM, Taylor MW. Type 1 interferon as an antiinflammatory agent: inhibition of lipopolysaccharide-induced interleukin-1 beta and induction of interleukin-1 receptor antagonist. J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res. 1995;15(4):317\u201321.","journal-title":"J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res"},{"issue":"2","key":"1691_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.immuni.2011.02.006","volume":"34","author":"G Guarda","year":"2011","unstructured":"Guarda G, Braun M, Staehli F, et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity. 2011;34(2):213\u201323.","journal-title":"Immunity"},{"issue":"20","key":"1691_CR13","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1007\/s00018-012-0989-2","volume":"69","author":"K Ludigs","year":"2012","unstructured":"Ludigs K, Parfenov V, Du Pasquier RA, Guarda G. Type I IFN-mediated regulation of IL-1 production in inflammatory disorders. Cell Mol Life Sci CMLS. 2012;69(20):3395\u2013418.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"1691_CR14","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/rheumatology\/35.11.1188","volume":"35","author":"E Tankurt","year":"1996","unstructured":"Tankurt E, Tunca M, Akbaylar H, Gonen O. Resolving familial Mediterranean fever attacks with interferon alpha. Br J Rheumatol. 1996;35:1188\u20139.","journal-title":"Br J Rheumatol"},{"issue":"11","key":"1691_CR15","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1136\/ard.2003.019471","volume":"63","author":"K Ureten","year":"2004","unstructured":"Ureten K. Interferon alfa in protracted arthritis of familial Mediterranean fever: a robust alternative for synovectomy. Ann Rheum Dis. 2004;63(11):1527.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1691_CR16","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/rheumatology\/36.9.1005","volume":"36","author":"M Tunca","year":"1997","unstructured":"Tunca M, Tankurt E, Akbaylar Akpinar H, Akar S, Hizli N, G\u00f6nen O. The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: a pilot study. Br J Rheumatol. 1997;36(9):1005\u20138.","journal-title":"Br J Rheumatol"},{"issue":"7","key":"1691_CR17","first-page":"1362","volume":"35","author":"N Tweezer-Zaks","year":"2008","unstructured":"Tweezer-Zaks N, Rabinovich E, Lidar M, Livneh A. Interferon-alpha as a treatment modality for colchicine-resistant familial Mediterranean fever. J Rheumatol. 2008;35(7):1362\u20135.","journal-title":"J Rheumatol"},{"issue":"4 Suppl 34","key":"1691_CR18","first-page":"S41","volume":"22","author":"M Calguneri","year":"2004","unstructured":"Calguneri M, Apras S, Ozbalkan Z, Ozturk MA, Ertenli I, Kiraz S. The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patients. Clin Exp Rheumatol. 2004;22(4 Suppl 34):S41\u20134.","journal-title":"Clin Exp Rheumatol"},{"issue":"4 Suppl 34","key":"1691_CR19","first-page":"S37","volume":"22","author":"M Tunca","year":"2004","unstructured":"Tunca M, Akar S, Soyt\u00fcrk M, et al. The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: A double-blind, placebo-controlled trial. Clin Exp Rheumatol. 2004;22(4 Suppl 34):S37\u201340.","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"1691_CR20","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1046\/j.1365-2036.2000.00857.x","volume":"14","author":"M Angelico","year":"2000","unstructured":"Angelico M, Cepparulo M, Barlattani A, et al. Unfavourable effects of colchicine in combination with interferon-alpha in the treatment of chronic hepatitis C. Aliment Pharmacol Ther. 2000;14(11):1459\u201367.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1691_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1099\/vir.0.034033-0","volume":"93","author":"D Burdette","year":"2012","unstructured":"Burdette D, Haskett A, Presser L, McRae S, Iqbal J, Waris G. Hepatitis C virus activates interleukin-1 via caspase-1-inflammasome complex. J Gen Virol. 2012;93(2):235\u201346.","journal-title":"J Gen Virol"},{"issue":"1","key":"1691_CR22","doi-asserted-by":"publisher","first-page":"e84953","DOI":"10.1371\/journal.pone.0084953","volume":"9","author":"W Chen","year":"2014","unstructured":"Chen W, Xu Y, Li H, et al. HCV Genomic RNA Activates the NLRP3 Inflammasome in Human Myeloid Cells. PLoS One. 2014;9(1):e84953. Sutterwala FS, ed","journal-title":"PLoS One"},{"issue":"7","key":"1691_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","volume":"12","author":"G Szabo","year":"2015","unstructured":"Szabo G, Petrasek J. Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol. 2015;12(7):387\u2013400.","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1691-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-018-1691-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1691-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T23:11:54Z","timestamp":1558134714000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-018-1691-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,18]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1691"],"URL":"https:\/\/doi.org\/10.1186\/s13256-018-1691-2","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,18]]},"assertion":[{"value":"9 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics committee approval and consent to participate are not applicable to our case report because this patient underwent regular medical procedures as any other patient admitted to our hospital; no additional investigations or experimental treatments were carried out.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"130"}}